This is the authors' abstract. We don't add key points for this paper.
ABC transporters protect the brain by transporting neurotoxic compounds from the brain back into the blood. P-glycoprotein (P-gp) is the most investigated ABC (efflux) transporter, as it is implicated in neurodegenerative diseases such as Alzheimer's disease. Altered function of P-gp can be studied in vivo, using Positron Emission Tomography (PET). To date, several radiopharmaceuticals have been developed to image P-gp function in vivo. So far, attempts to image expression levels of P-gp using radiolabeled P-gp inhibitors have not been successful. Improved knowledge of compound behavior toward P-gp from in vitro studies should increase predictability of in vivo outcome.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Raaphorst et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: